Janet Kwiatkowski founded MAE Group in 2013 in order to bring life-saving devices to global markets. With Janet as the lead, MAE Group began partnering with medical device, bioscience and life science companies by providing global regulatory affairs, clinical affairs, quality management, and program management services to commercialize products in target markets. MAE Group continues to provide these services to start-up and SME (Small and Medium Enterprises) as well as large blue-chip companies.
MAE Group expertise lies with our in-depth knowledge of regulations and most importantly, interpretation and application of the requirements, to guide any company through the commercialization pathway to successful product launch with strategic and tactical alignment to business plans. MAE Group has established an excellent reputation with global regulatory bodies. We are honored to partner with a multitude of companies to bring devices to the world.
In 2021, MAE Group expanded the company’s vision leading the commercialization of a thermobrachytherapy oncology medical device, a platform technology, under the MAE Group brand.
MAE Group brings lifesaving medical devices to global markets.